Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.

NCT00408473 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Flecainide

Sponsor

MEDA Pharma GmbH & Co. KG

Collaborators

[object Object]